Lexaria Bioscience Corp. (LEXX)
0.9736
-0.06
(-5.48%)
USD |
NASDAQ |
Apr 16, 13:46
Lexaria Bioscience Total Liabilities (Quarterly) : 0.277M for Feb. 28, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 11.38M |
| Aurinia Pharmaceuticals, Inc. | 189.26M |
| Edesa Biotech, Inc. | 0.7562M |
| Xenon Pharmaceuticals, Inc. | 399.91M |
| ProMIS Neurosciences, Inc. | 10.44M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.487M |
| Shareholders Equity (Quarterly) | 6.602M |
| Debt to Equity Ratio | 0.0143 |
| Current Ratio | 26.88 |
| Net Debt Paydown Yield | 0.04% |